Search

everythinglearnresearchcommunity

for

Search:↓

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Skin fat has important roles in hair growth, skin repair, immune defense, and aging, and could be targeted for skin and hair treatments.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Minoxidil boosts hair growth by triggering growth factor release from specific stem cells.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Radiofrequency exposure can stimulate hair growth by increasing IGF-1 in hair follicle cells.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Both genetic and lifestyle factors significantly affect female hair loss.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Oral contraceptives may cause hair loss in women.

The document concludes that more research is needed to fully understand the causes of PCOS.

Higher thyroid hormone levels may be linked to certain types of polycystic ovary syndrome.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Women with PCOS have lower zinc levels.

The Shh gene controls cell growth and death in cashmere goat hair follicles, affecting hair growth.

Combining yoga and certain herbs can effectively manage PCOS symptoms and improve quality of life.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.